+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Myeloma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 230 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
FGFRpositive Gastroesophageal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

FGFRpositive Gastroesophageal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2025 - Product Thumbnail Image

Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Metastatic Urothelial Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Urothelial Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Caspase 3 (CPP32, Apopain Or YAMA) Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Caspase 3 (CPP32, Apopain Or YAMA) Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Oligodendroglioma - Pipeline Insight, 2025 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hepatic - Colorectal Metastasis - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatic - Colorectal Metastasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Familial Adenomatous Polyposis Coli - Pipeline Insight, 2025 - Product Thumbnail Image

Familial Adenomatous Polyposis Coli - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-Lymphotoxin - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-Lymphotoxin - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD80 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD80 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD52 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD52 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD40 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD40 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD37 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD37 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Metastatic Liver Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Liver Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Medulloblastoma- Pipeline Insight, 2025 - Product Thumbnail Image

Medulloblastoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more